REVMATOID ARTRIT KASALLIGINING SUN'IY INTELLEKT DAVRIDA ZAMONAVIY DAVOLASH USULLARI KASALLIKNING OLDINI OLISH CHORALARI
Keywords:
Keywords: rheumatoid arthritis, artificial intelligence, autoimmune diseases, biological therapy, disease-modifying antirheumatic drugs DMARDs, Janus kinase inhibitors, personalized medicine, diagnosis, prevention, modern treatment approaches.Abstract
Abstract. Rheumatoid arthritis is a chronic autoimmune disease characterized primarily by joint inflammation, deformity, and progressive impairment of functional capacity. The progression of the disease not only adversely affects patients’ quality of life but also contributes to loss of work capacity and increased disability rates. In recent years, the rapid development of artificial intelligence technologies in healthcare has created new opportunities for the early diagnosis of rheumatoid arthritis, evaluation of treatment effectiveness, and development of individualized therapeutic strategies. This article analyzes contemporary approaches to the treatment of rheumatoid arthritis and examines the role of artificial intelligence technologies in this process. In particular, the advantages of biological agents, disease-modifying antirheumatic drugs DMARDs, Janus kinase inhibitors, and targeted therapies are discussed. The application of artificial intelligence algorithms enables the comprehensive analysis of clinical, laboratory, and radiological data, facilitating disease prognosis, prediction of treatment response, and implementation of personalized medicine approaches in clinical practice. Special attention is also given to preventive measures aimed at reducing the risk of rheumatoid arthritis. Regular medical monitoring of individuals with genetic predisposition, adherence to a healthy lifestyle, smoking cessation, balanced nutrition, increased physical activity, and early detection of inflammatory processes are considered important factors in reducing the likelihood of disease development. The findings indicate that artificial intelligence–based diagnostic and therapeutic approaches demonstrate high effectiveness in the management of rheumatoid arthritis. Furthermore, the integration of AI technologies into clinical practice has the potential to improve diagnostic accuracy, optimize treatment outcomes, and support evidence-based decision-making. The results of current studies suggest that the widespread implementation of artificial intelligence technologies may contribute significantly to the early detection of rheumatoid arthritis, reduction of disease-related complications, and improvement of patients’ quality of life. Consequently, the combination of advanced therapeutic strategies and AI-driven healthcare solutions represents a promising direction for the future management and prevention of rheumatoid arthritis.
References
1.Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR. Kelley's Textbook of Rheumatology. 11th ed. Philadelphia: Elsevier; 2021.
2.Fraenkel L, Bathon JMSmole, England BR, St Clair EW, Arayssi T, Carandang K, et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res. 2021;73(7):924–939.
3.Topol EJ. Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again. New York: Basic Books; 2019.
4.Jiang F, Jiang Y, Zhi H, Dong Y, Li H, Ma S, et al. Artificial intelligence in healthcare: Past, present and future. Stroke Vasc Neurol. 2017;2(4):230–243.
5.Esteva A, Robicquet A, Ramsundar B, Kuleshov V, DePristo M, Chou K, et al. A guide to deep learning in healthcare. Nat Med. 2019;25(1):24–29.
6.Wang L, Wang Y, Ye D, Liu Q. A review of the 2020 COVID-19 pandemic and the role of artificial intelligence in healthcare. Front Public Health. 2021;9:655466.
7.Насонов Е.Л. Ревматология: Клинические рекомендации. Москва: ГЭОТАР-Медиа; 2022.
8.Karimov SH, Abdullayev AA. Revmatoid artritning zamonaviy diagnostikasi va davolash tamoyillari. Tibbiyot va Zamon. 2023;4(2):45–51.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal